Satish Reddy

Faced with increasing regulatory scrutiny -- Indian drug makers working more closely then ever before on Friday said they have been investing on automation, simplifying and standardizing systems and working on building culture of compliance within their organizations -- as they don‘t want to be seen as outliers in terms of regulatory compliance.

Govt needs to be a strong enabler in pharma sector: Experts

Shereen Bhan speaks with top bosses from the pharma sector along with KT Rama Rao, Minister of IT, Telangana at Bioasia 2017 to discuss way forward for pharma sector in making India healthier.

USFDA actions hurting exports, need govt intervention: DrReddy's

Exports of pharma although grew by 9.7 per cent but it used to be in double digits in the past so it has come down slightly, Reddy said.

Plan to revamp systems as per FDA expectations: Dr Reddy's

Speaking on acquisitions, Satish Reddy, Chairman of Dr Reddy's said they are always on the lookout for strategic fits to boost growth.

Dr Reddy's launches new corporate brand identity

Drug firm Dr Reddy's Laboratories on Wednesday announced an image makeover with the launch of a new visual identity and brand.

R&D spend to go up by 9-10% in next few years: Dr Reddy‘s

Dr Reddy's Labs has signed an agreement with Galena Biopharma to develop NeuVax in India.

Glenmark's R&D gamble

With Indian pharma companies willing to cash out, is Glenn Saldanha India’s best bet for a home-grown drug?

Dr Reddy's buys JB Chemicals' prescription biz in Russia

Dr Reddy's has entered into an agreement to buy JB Chemicals & Pharmaceuticals' prescription portfolio in Russia and other CIS countries for USD 34.85 million or about Rs 137.5 crore.